CHIRAL DRUGSстатья из журнала
Аннотация: RETURN TO ISSUEPREVNewsNEXTCHIRAL DRUGSIn wake of new FDA guidelines, most drug firms are developing single enantiomers, spawning a "chirotechnology" industrySTEPHEN C. STINSONView Author Information C&EN Northeast News BureauCite this: Chem. Eng. News 1992, 70, 39, 46–79Publication Date (Print):September 28, 1992Publication History Published online10 November 2010Published inissue 28 September 1992https://pubs.acs.org/doi/10.1021/cen-v070n039.p046https://doi.org/10.1021/cen-v070n039.p046newsACS PublicationsCopyright © 1992 American Chemical SocietyArticle Views52Altmetric-Citations134LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access options SUBJECTS:Molecular structure,Pharmaceuticals Get e-Alerts
Год издания: 1992
Авторы: STEPHEN STINSON
Издательство: American Chemical Society
Источник: Chemical & Engineering News
Ключевые слова: Analytical Chemistry and Chromatography, Various Chemistry Research Topics, Chemistry and Chemical Engineering
Открытый доступ: closed
Том: 70
Выпуск: 39
Страницы: 46–79